「从湾区启航:「南海I号」与海上丝绸之路」展览开幕
香港, 2024年8月16日 – (亚太商讯 via SeaPRwire.com) – 由发展局、国家文物局和澳门特别行政区政府社会文化司合办的「从湾区启航：『南海I号』与海上丝绸之路」展览于八月十五日举行开幕礼。展览展出「南海I号」远洋商船的出土文物及粤港澳三地的相关文物，以展示粤港澳大湾区在海上丝绸之路…
卫龙美味公布2024年中期业绩
香港, 2024年8月16日 – (亚太商讯 via SeaPRwire.com) – 中国辣味休闲食品行业龙头企业，卫龙美味全球控股有限公司（「卫龙美味」或「集团」）及附属公司（「集团」）（香港联交所股票代码：09985）公布截至2024年6月30日止六个月（「期内」）未经审核之中期业绩。 2024年上半…
第四范式发布2024年中期业绩
财务摘要︰– 2024年上半年总收入人民币18.67亿元，同比增长27.1% – 先知AI平台业务收入为人民币 12.51亿元，同比增长65.4%，占总收入的比例升至67.0% – SHIFT智能解决方案业务收入为人民币4.53亿元，占总收入的24.3% – 式说A…
越秀房产基金整体经营稳定 实现收入逾人民币10亿元
香港, 2024年8月15日 – (亚太商讯 via SeaPRwire.com) – 越秀房地产投资信托基金（「越秀房产基金」，连同越秀房托资产管理有限公司，统称「基金」；股份代号：405）公布其截至2024年6月30日止六个月之中期业绩。 越秀房产基金管理团队：主席兼行政总裁及执行董事林德良先生（左二）…
Genes Tech Group Announces 2024 Interim Results
HONG KONG, Aug 14, 2024 – (ACN Newswire via SeaPRwire.com) – Genes Tech Group Holdings Co. Ltd (“Genes Tech Group” or “The Group”; Stock Code: 8257.HK) announces its interim results for the […]
AsiaMedic continues growth streak with 23% increase in revenue for First Half ended 30 June 2024
SINGAPORE, Aug 14, 2024 – (ACN Newswire via SeaPRwire.com) – SGX Catalist-listed AsiaMedic Limited (the “Company” and together with its subsidiaries, the “Group”) announced its financial results for the financial period ended 30 […]
Kincora Participation in the Sharewise Webinar
Melbourne, Australia–(ACN Newswire via SeaPRwire.com – August 14, 2024) – Kincora Copper Limited (ASX: KCC) (TSXV: KCC) (Kincora or the Company) is pleased to be participating in the Sharewise Webinar to be […]
Egyptian Heritage and Palestinian Folklore Shine at Alamein Festival
Egyptian Folk Traditions Take Centre Stage at Alamein Iconic Performances Celebrate Egyptian and Palestinian Heritage Opera Al Layla Al-Kabira and Reda Troupe Steal the Show AL ALAMEIN CITY, EGYPT, Aug 15, 2024 […]
Solar District Cooling Group Berhad Signs Underwriting Agreement with Mercury Securities Sdn Bhd for Its IPO on the ACE Market of Bursa Malaysia Securities Berhad
KUALA LUMPUR, Aug 14, 2024 – (ACN Newswire via SeaPRwire.com) – Solar District Cooling Group Berhad (“SDCG”) is pleased to announce that it has entered into an underwriting agreement with Mercury Securities […]
新能源助推绿色转型 中国港能打造智慧能源新蓝图
香港, 2024年8月14日 – (亚太商讯 via SeaPRwire.com) – 中国港能智慧能源集团有限公司（股份代号：0931.HK，以下简称“中国港能”）在香港成功召开2024年度业绩投资者交流会。本次活动是自中国港能战略转型后首次面向全球投资者举办的线下交流会，不仅是中国港能在全球能源版图中迈…
Kincora and AngloGold Ashanti’s First Drilling Program
The first ever copper-gold focused drilling program at the northern portion of the Nyngan Project will shortly commence with earn-in partner AngloGold Ashanti Australia (AngloGold Ashanti). New district-scale potential with up to […]
Experience Eternal Romance with Exquisite Blue Diamonds by ALUXE
SINGAPORE, Aug 14, 2024 – (ACN Newswire via SeaPRwire.com) – ALUXE, cherished for its unwavering commitment to celebrating love and happiness, is delighted to introduce 8 stunning new additions to its exclusive “Lovers” […]
Nissin Foods Becomes a Constituent of MSCI Global Micro Cap Index (MSCI Hong Kong Index)
HONG KONG, Aug 14, 2024 – (ACN Newswire via SeaPRwire.com) – Nissin Foods Company Limited (“Nissin Foods” or the “Company”, together with its subsidiaries, the “Group”; Stock code: 1475) is pleased to […]
日清食品为MSCI全球微型股指数（MSCI香港指数）成份股之一
香港, 2024年8月14日 – (亚太商讯 via SeaPRwire.com) – 日清食品有限公司（「日清食品」或「公司」，连同其附属公司统称「集团」；股份代号：1475）欣然宣布集团已获纳入MSCI全球微型股指数（MSCI香港微型股指数），将于2024年8月30日（星期五）生效。 日清食品执行董事、…
Modern DevOps Melbourne 2024 Partners with ACN Newswire; Offers Exclusive Discount
MELBOURNE, Aug 14, 2024 – (ACN Newswire via SeaPRwire.com) – Mark your calendars for an unmissable event! We are thrilled to announce our partnership with the upcoming Modern DevOps Melbourne, taking place […]
Experience Eternal Romance with Exquisite Blue Diamonds
SINGAPORE, Aug 14, 2024 – (ACN Newswire via SeaPRwire.com) – ALUXE, cherished for its unwavering commitment to celebrating love and happiness, is delighted to introduce 8 stunning new additions to its exclusive “Lovers” […]
Sino Biopharmaceutical (1177.HK) Announces 2024 Interim Results
Development Highlights – During the reporting Period, four of the Group’s innovative products were approved for marketing by the National Medical Products Administration of China (“NMPA”), namely Andewei (Benmelstobart Injection), Anboni (Unecritinib […]
中国生物制药（1177.HK）公布2024中期业绩
重点成果 – 期内，集团共有4个创新产品获中国国家药品监督管理局（「NMPA」）批准上市，分别为安得卫（贝莫苏拜单抗注射液）、安柏尼（富马酸安奈克替尼胶囊）、安洛晴（枸橼酸依奉阿克胶囊）和贝乐林（利拉鲁肽注射液），其中3个为国家1类创新药。 – 2024年上半年，集团创新产品收入达到61.3亿元…